Nykode Therapeutics ASA (NYKD) — Financial Flexibility Index
Nykode Therapeutics ASA (NYKD) has a Financial Flexibility Index of -1.11x as of June 2026. Free cash flow of Nkr-6.35 Million (operating CF Nkr-6.35 Million minus capex Nkr0.00) represents -1% of total liabilities (Nkr5.73 Million). Check NYKD cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nykode Therapeutics ASA Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Nykode Therapeutics ASA across 10 annual periods. For the full cash flow conversion analysis, see Nykode Therapeutics ASA cash conversion from operations.
Annual Financial Flexibility Index for Nykode Therapeutics ASA (2016–2025)
Year-by-year free cash flow to debt coverage for Nykode Therapeutics ASA. Explore Nykode Therapeutics ASA (NYKD) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.49x | Nkr-29.42 Million | Nkr-29.46 Million | Nkr8.42 Million | ▼ -18.0% |
| 2024 | -2.96x | Nkr-51.15 Million | Nkr-51.22 Million | Nkr17.27 Million | ▼ -15.5% |
| 2023 | -2.57x | Nkr-94.72 Million | Nkr-96.62 Million | Nkr36.93 Million | ▼ -817.7% |
| 2022 | -0.28x | Nkr-18.02 Million | Nkr-20.69 Million | Nkr64.46 Million | ▼ -1086.5% |
| 2021 | 0.03x | Nkr2.03 Million | Nkr1.16 Million | Nkr71.50 Million | ▼ -99.2% |
| 2020 | 3.52x | Nkr180.37 Million | Nkr180.27 Million | Nkr51.18 Million | ▲ +294.8% |
| 2019 | -1.81x | Nkr-91.41 Million | Nkr-92.08 Million | Nkr50.52 Million | ▲ +61.7% |
| 2018 | -4.73x | Nkr-62.70 Million | Nkr-62.78 Million | Nkr13.27 Million | ▲ +17.6% |
| 2017 | -5.73x | Nkr-62.70 Million | Nkr-62.78 Million | Nkr10.94 Million | ▼ -527.0% |
| 2016 | -0.91x | Nkr-1.59 Million | Nkr-1.60 Million | Nkr1.74 Million | — |